Melike Şeyda Dağdelen

Melike Şeyda Dağdelen

Auto-generated profile, based on publicly available information

Melike Şeyda Dağdelen

Department of Anesthesiology and Intensive Care, Health Ministry of the Turkish Republic, Bursa City Hospital, Bursa, Türkiye

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2023 in Turkish Journal of Intensive Care
Verified
Journal Article
Open access
DGDerful Gulen
Derful Gulen
MDMelike Şeyda Dağdelen
Melike Şeyda Dağdelen
ICIlkay Ceylan
Ilkay Ceylan
NGNermin Kelebek Girgin
Nermin Kelebek Girgin
Amaç: İlaç-ilaç etkileşimi (İİE), birden fazla ilacın birlikte kullanımıyla ortaya çıkan, advers ilaç reaksiyonlarından (AİR) olup, ilaçların tedavideki etkinliğinin azalması ve komplikasyonlarla ilişkilidir. Yoğun bakım ünitesi (YBÜ) hastalarında çoklu ilaç kullanımı potansiyel İİE açısından bu hastaları risk grubu haline getirmektedir. Çalışmamızda, ülkemizdeki farklı yoğun bakımlarında benzer hasta gruplarındaki potansiyel ilaç-ilaç etkileşimlerini (pİİE) belirlemek istedik. Gereç ve Yöntem: Bu çalışma Türkiye’deki YBÜ’de yatan kritik hastalarda çok merkezli nokta prevalans çalışması olarak tasarlanmıştır. Hasta orderları Lexi interact online interaction checker program (https: //www.uptodate.com/drug-interactions) ile pİİE açısından analiz edildi. Bulgular: İki yüz otuz altı hasta verisi içinden yaş

17 April 2019 in International Journal of Anesthetics and Anesthesiology
Verified
Journal Article
Open access
DŞDağdelen Melike Şeyda
Dağdelen Melike Şeyda
AYAbut Fatma Yeşim
Abut Fatma Yeşim
EVErden Veysel
Erden Veysel
SSSeven Seda
Seven Seda
The purpose of this study was to evaluate adding an obturator nerve block to adductor canal block may reduce tramadol consumption (primary endpoint), improve pain relief, enhance early ambulation ability, and reduce side effects (secondary endpoints) after TKA compared with single adductor canal block.

11 September 2020 in Turkish Journal of Intensive Care
Verified
Journal Article
Open access
AEAytül Coşar Ertem
Aytül Coşar Ertem
MDMelike Şeyda Dağdelen
Melike Şeyda Dağdelen
SYSimge Yıldız
Simge Yıldız
FKFerda Şöhret Kahveci
Ferda Şöhret Kahveci
NKNermin Kelebek
Nermin Kelebek
RIRemzi İşÇimen
Remzi İşÇimen
Tiroid fırtınası, hızla tedavi edilmediğinde çoklu organ yetersizliği ve mortalite artışı ile sonuçlanan klinik bir durumdur. Genel tedavi seçenekleri; antitiroid ilaçlar, radyoaktif iyot ve tiroidektomi uygulamasıdır. Terapötik plazmaferez (TP); özellikle geleneksel tedavi yöntemleriyle başarılı olunamayan veya bu tedavi yöntemlerini tolere edemeyen hastalarda dengeleyici bir tedavi yaklaşımı olarak düşünülebilir. Bu olgu sunumuyla; TP’nin yaşamı tehdit eden koşullarda standart tedavi yöntemlerine eklenebilecek alternatif bir yaklaşım olabileceğini paylaşmak istedik.

10 September 2020 in Medical Bulletin of Haseki
Verified
Journal Article
Closed access
ICIlkay Ceylan
Ilkay Ceylan
MDMelike Şeyda Dağdelen
Melike Şeyda Dağdelen
SSSeda Seven
Seda Seven
SBSevim Baltalı
Sevim Baltalı
VEVeysel Erden
Veysel Erden

5 September 2025 in Medicine
Verified
Journal Article
Open access
MDMelike Seyda Dagdelen
Melike Seyda Dagdelen
IKIbrahim Koc
Ibrahim Koc
Using high-flow nasal cannula (HFNC) in patients with hypoxemic respiratory failure to avoid intubation raises concerns about its potential to increase mortality due to delayed intubation. Identifying at-risk patients is essential. While the literature predicts risk with oxygen-based indices (ROX, SpO 2 /FiO 2 , PaO 2 /FiO 2 ), we aimed to detect ventilation insufficiency. To achieve this, we developed a simplified and modified “ventilatory ratio” (VRm), assessed its predictive value, and compared it with the ROX index. In this retrospective, observational study, patients in the intensive care unit who received high-flow nasal cannula therapy were divided into 2 groups: a failure group, consisting of those who underwent intubation, and a success group. After excluding metabolic and organic disorders that could affect ventilation (such as chronic obstructive pulmonary disease, obesity hypoventilation, renal failure, and sepsis), data from 15 patients (7 non-intubated, 8 intubated) were analyzed. There were no significant differences between the 2 groups in terms of age, Apache II score, length of stay in the intensive care unit, arterial blood gas values, SpO 2 /FiO 2 or PaO 2 /FiO 2 . The ROX index and VRm values were significantly different in both groups. The diagnostic accuracy (area under the ROC curve – AUC) of the ROX index for predicting the need for intubation was significantly high, at 0.89 (95% CI: 0.63–0.99; P < .001). The optimal cutoff value for the ROX index was ≤ 3.92. The VRm index demonstrated a diagnostic accuracy of AUC = 0.93 (95% CI: 0.67–1) and was also significantly high ( P < .001). The optimal cutoff value for VRm was determined to be >2.68. Comparison of ROC curves between the ROX and VRm indices was not statistically significant (z = 0.41; P = .685). The VRm index may serve as a useful additional bedside tool for predicting HFNC therapy failure in hypoxemic pneumonia patients, especially in the gray zone of the ROX index.